Affiliations 

  • 1 Universiti Kebangsaan Malaysia Medical Centre, Cell Therapy Centre, Kuala Lumpur, Malaysia
  • 2 Universiti Kebangsaan Malaysia Medical Centre, Department of Medicine, Kuala Lumpur, Malaysia
  • 3 Universiti Kebangsaan Malaysia Medical Centre, Department of Pharmacy, Kuala Lumpur, Malaysia
  • 4 Prince Court Medical Centre, Kuala Lumpur, Malaysia
  • 5 Hospital Ampang, Department of Haematology, Pandan Mewah, Selangor, Malaysia
Med J Malaysia, 2018 12;73(6):430-432.
PMID: 30647224

Abstract

Immune Thrombocytopenia Purpura (ITP) secondary to vaccinations is rare, especially after autologous hematopoietic stem cell transplantation (HSCT). A 31-yearold female received autologous HSCT for relapsed Hodgkin Disease, with platelet engraftment at Day+14. One week after receiving second scheduled vaccinations, she developed severe thrombocytopenia (3x109/L) associated with pharyngeal hematoma. Bone marrow (BM) examinations were consistent with ITP, possibly secondary to Influenza vaccine. Platelet increment was poor despite high dose corticosteroids, intravenous immunoglobulin (IVIG), Danazol and Eltrombopag. A repeated BM biopsy was in agreement with ITP. Re-treatment with tapering doses of prednisolone resulted in stable platelet counts at 120x109/L a year later.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.